Medical Transcription Billing Revenue, Profits - MTBC Annual Income Statement

Add to My Stocks
$4.39 $0 (0%) MTBC stock closing price Aug 13, 2018 (Closing)

Looking at financial statements, along with the Medical Transcription Billing stock price, it's management, its economic moat, and industry competitors forms an important part of fundamental analysis. The income statement gives the investor an understanding of the topline or revenue and bottomline or profit numbers of the company and helps investors evaluate if a company has been growing or not. The income statement is generated for a specific period of time, typically a year or a quarter. The revenue increase to $31.81M for 2017 impacts the MTBC stock. Investors typically check year over year or quarter over quarter revenue growth. One also needs to look at Medical Transcription Billing assets, operating expenses and Medical Transcription Billing free cash flow. The Medical Transcription Billing profit and loss statement shows revenue of $31.81M for 2017. Revenue has grown by 29.89% YOY for MTBC stock.

View revenue and profit details for latest and last 10 financial years.
show more
Quarterly
Annual
View Previous Years
View Next Years
Fiscal year is Jan - Dec201720162015201420132012
Medical Transcription Billing Revenues or Net Sales
31.81M24.49M23.07M18.3M10.47M10.01M
Cost Of Goods Sold (COGS)17.67M13.41M11.63M10.63M4.27M4.25M
Medical Transcription Billing Gross Profit
14.13M11.07M11.44M7.66M6.19M5.76M
Research & Development Expense1.08M-----
Selling General & Admin Expense13.27M12.96M10.65M8.38M4.99M4.66M
Income Before Depreciation Depletion Amortization-0.22M-2.79M--1.24M--
Depreciation Depletion Amortization4.29M5.1M4.59M2.79M--
Non Operating Income--0.01M--0.1M--
Interest Expense1.32M-----
Medical Transcription Billing Pretax Income
-5.49M-8.59M-4.54M-4.33M-0.03M-
Provision for Income Taxes------
MinorityInterest------
Investment Gains Losses------
Other Income------
Income Before Extraordinaries & Disc Operations-5.56M-8.79M-4.68M-4.5M-0.17M-
Extraordinary Items & Discontinued Operations------
Medical Transcription Billing Profit/ Loss (Net Income)
-5.56M-8.79M-4.68M-4.5M-0.17M-
Average Shares used to compute Diluted EPS11.01M10.04M9.73M7.09M10.98M-
Average Shares used to compute Basic EPS11.01M10.04M9.73M7.09M10.98M-
Income Before Nonrecurring Items-1.45M-3.91M-2.01M-2.61M-2.45M-
Income from Nonrecurring Items-4.11M-4.89M-2.68M-1.9M--
Medical Transcription Billing Earnings Per Share Basic Net
-0.69-0.95-0.50-0.64-0.22-
Medical Transcription Billing Earnings Per Share Diluted Net
-0.69-0.95-0.50-0.64-0.22-
EPS Diluted Before Nonrecurring Items-0.13-0.38-0.19-0.23-0.22-
Preferred Dividends Acc Pd------
Dividends Common------
Dividend Per Share Common0.000.000.000.000.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

The key things to look for in an income statement while doing Medical Transcription Billing stock analysis are:

  • Revenue: This is the inflow that is generated from the sale of goods or services and is $31.81M for this year of 2017. Our Medical Transcription Billing revenue chart gives a clear visual representation of how the topline or sales growth has been. Investors often invest only in those companies where the revenue is growing at a steady rate.
  • Bottom line: The bottomline or the net income figure is arrived at by deducting all expenses from the topline which in this case is $-5.56M for MTBC stock. An improving bottomline implies that the company is growing its profits.

The income statement is also called the profit and loss statement. Apart from the MTBC income statement, one can check the Medical Transcription Billing historical stock prices to check how the price has moved with time.

Medical Transcription Billing Income Statement - Key Financial Ratios

PS Ratio (price sales ratio)
1.6
Operating Margin
0.4
Net Profit Margin
1
Dividend Yield
0%